{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:07:12Z","timestamp":1787785632244,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            Spasticity is a disabling complication of stroke and different noninvasive treatments are used to reduce muscle hypertonia. Shock waves are defined as a sequence of single sonic pulses largely used in the treatment of diseases involving bone and tendon as well as muscular contractures. The effect and duration of extracorporeal shock wave therapy (ESWT) was investigated on muscle hypertonia of the hand and wrist.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            A total of 20 patients affected by stroke associated with severe hypertonia in upper limbs were evaluated. Placebo stimulation was performed 1 week before active stimulation in each patient. Evaluation was performed using the National Institutes of Health and Ashworth scales and video monitoring with a digital goniometer before and immediately after placebo or active stimulation. Motor nerve conduction velocity from abductor digiti minimi were recorded. Patients were monitored at 1, 4, and 12 weeks after active treatment.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            After active ESWT, patients showed greater improvement in flexor tone of wrist and fingers compared with placebo stimulation. At the 1- and 4-week follow-up visits, a significant decrease of passive muscle tonicity was noted on muscles in all patients receiving active treatment. At 12 weeks after therapy, 10 of the 20 patients showed persistent reduction in muscle tone. There were no adverse events associated with ESWT.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            ESWT reduces hypertonia of the wrist and finger muscles for \u226512 weeks after treatment. The possible mechanisms of action of ESWT are discussed.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000177880.06663.5c","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:34:56Z","timestamp":1124411696000},"page":"1967-1971","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":140,"title":["Long-Term Effect of Shock Wave Therapy on Upper Limb Hypertonia in Patients Affected by Stroke"],"prefix":"10.1161","volume":"36","author":[{"given":"P.","family":"Manganotti","sequence":"first","affiliation":[{"name":"From the Hand Surgery Department (P.M.) and Neurological Rehabilitation, Department of Neurological Sciences and Vision (E.A.), Verona Hospital, University of Verona, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Amelio","sequence":"additional","affiliation":[{"name":"From the Hand Surgery Department (P.M.) and Neurological Rehabilitation, Department of Neurological Sciences and Vision (E.A.), Verona Hospital, University of Verona, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"S1","year":"1997","unstructured":"Mayer NH. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve. 1997; (suppl 6): S1\u2013S13.","journal-title":"Muscle Nerve"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011892"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1306"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-200007000-00010"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1191\/026921500666642221"},{"key":"e_1_3_2_6_2","first-page":"6","volume":"26","year":"2000","unstructured":"Russo S, Marlinghaus E, Amelio E, Corrado B, Galasso O, Cugola L, Corrado EM. Le onde d\u2019urto nel trattamento della pseudoartrosi: valutazione clinica e sperimentale della risposta neo-osteo-angiogenetica. Giornale Italiano di Ortopedia e Trumatologia. 2000; 26: 6\u201312.","journal-title":"Giornale Italiano di Ortopedia e Trumatologia"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Siebrt W Buch M. Extracorporeal Shock Wave in Orthopaedics. Heidelberg Berlin Germany: Springer-Verlag; 1998.","DOI":"10.1007\/978-3-642-80427-4"},{"key":"e_1_3_2_8_2","first-page":"181","volume":"15","year":"1991","unstructured":"Valchanov VD, Michailov P. High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop. 1991; 15: 181\u2013184.","journal-title":"Int Orthop"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1058-2746(98)90203-8"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1302\/0301-620X.81B5.0810863","volume":"81","year":"1999","unstructured":"Loew M, Deacke W, Kusnierczak D, Rahmanzadeh M, Ewerbeck V. Shock-wave therapy is effective for chronic calcifying tendinitis of the shoulder. J Bone Joint Surg Br. 1999; 81B: 863\u2013867.","journal-title":"J Bone Joint Surg Br"},{"key":"e_1_3_2_11_2","first-page":"233","volume":"78","year":"1996","unstructured":"Rompe JD, Hopf C, Kullmer K, Heine J, Burger R. Analgesic effect of ESWT on chronic tennis elbow. J Bone Joint Surg Br. 1996; 78B: 233\u2013237.","journal-title":"J Bone Joint Surg Br"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/03635465030310021901"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007760100013"},{"key":"e_1_3_2_14_2","first-page":"84","volume":"21","year":"1999","unstructured":"Russo S, de Durante C, Gigliotti S, Galasso O. Shock wave management of footballer\u2019s tendinopathies. J Sports Traumatol rel res. 1999; 21: 84\u201388.","journal-title":"J Sports Traumatol rel res"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Lohse-Busch H Kraemer M Reime U. The use of extracorporeal shock wave fronts for treatment of muscle dysfunction of various etiologies: an overview of first results. In: Siebert W Buch M eds. Extracorporeal Shock Waves in Orthopaedics. Berlin Heidelberg Germany: Springer; 1997: 215\u2013230.","DOI":"10.1007\/978-3-642-80427-4_14"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.25.11.7974549"},{"key":"e_1_3_2_17_2","first-page":"540","volume":"192","year":"1964","unstructured":"Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964; 192: 540\u2013542.","journal-title":"Practitioner"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-2457(02)00062-7"},{"key":"e_1_3_2_19_2","first-page":"n.3.","volume":"52","year":"2003","unstructured":"Mariotto S, Cavalieri E, Ciampa A, Carcereri de Prati A, Amelio E, Russo S, Marlinghaus E, Suzuki H. Effect of shock wave on the catalytic activity of endothelial nitric oxide synthase in umbilical vein endothelial cells. The Ital J Biochem. 2003; 52: n.3.","journal-title":"The Ital J Biochem"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)02807-7"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2004.12.005"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002512-199812040-00001","volume":"12","year":"1998","unstructured":"Molina JA, Jimenez-Jimenez FJ, Ort\u00ec-Pareja M, Navarro JA. The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging. 1998; 12:4: 251\u2013259.","journal-title":"Drugs Aging"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.1168"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/68.4.475"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20010"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000177880.06663.5c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T21:39:11Z","timestamp":1715549951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000177880.06663.5c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1161\/01.STR.0000177880.06663.5c"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000177880.06663.5c","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"2004-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-06-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}